Restatement of Previously Issued Condensed Consolidated Financial Statements - Statements of Operations and Comprehensive Loss (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
		Mar. 31, 2024		Mar. 31, 2023
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net revenue		$ 61,082		$ 52,036
Cost of goods sold		13,842	[1]	10,229
Gross profit		47,240		41,807
Operating expenses
Research and development costs		7,584		7,049
Selling, general, and administrative		54,782	[2]	43,820
Total operating expenses		62,366		50,869
Operating loss		(15,126)		(9,062)
Other income (expense):
Other income (expense), net		515		(616)
Interest expense, net		(2,622)		(1,205)
Total other expense, net		(2,107)		(1,821)
Loss before income taxes		(17,233)		(10,883)
Income tax expense (benefit)		166	[3]	(71)
Net loss		(17,399)	[1],[2],[3]	(10,812)
Foreign currency translation adjustment		(1,097)		(99)
Comprehensive loss		$ (18,496)		$ (10,911)
Weighted average number of shares of common stock outstanding:
Basic		82,854,334		80,681,715
Diluted		82,854,334		80,681,715
Net loss per share attributable to common stockholders:
Basic		$ (0.21)		$ (0.13)
Diluted		$ (0.21)		$ (0.13)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net revenue		$ 61,082
Cost of goods sold		12,186
Gross profit		48,896
Operating expenses
Research and development costs		7,584
Selling, general, and administrative		54,215
Total operating expenses		61,799
Operating loss		(12,903)
Other income (expense):
Other income (expense), net		515
Interest expense, net		(2,622)
Total other expense, net		(2,107)
Loss before income taxes		(15,010)
Income tax expense (benefit)		224
Net loss		(15,234)
Foreign currency translation adjustment		(1,097)
Comprehensive loss		$ (16,331)
Weighted average number of shares of common stock outstanding:
Basic		82,854,334
Diluted		82,854,334
Net loss per share attributable to common stockholders:
Basic		$ (0.18)
Diluted		$ (0.18)
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cost of goods sold		$ 1,656
Gross profit		(1,656)
Operating expenses
Selling, general, and administrative		567
Total operating expenses		567
Operating loss		(2,223)
Other income (expense):
Loss before income taxes		(2,223)
Income tax expense (benefit)		(58)
Net loss	[1],[2],[3]	(2,165)
Comprehensive loss		$ (2,165)
Net loss per share attributable to common stockholders:
Basic		$ (0.03)
Diluted		$ (0.03)

[1] Inventory Treatment - The correction of the misstatement resulted in an increase to Cost of goods sold of $1,656 for the three-months ended March 31, 2024.

[2] Trade Receivable Reserve - The correction of the misstatement resulted in an increase to Selling, general and administrative of $567 for the three-months ended March 31, 2024.

[3] Income Tax Adjustment - The correction of the misstatement resulted in a decrease to Income tax expense (benefit) of $58 for the three-months ended March 31, 2024.